DocStoX is a free AI-powered research platform for Indian equity markets, covering 6,800+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (6,800+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 74 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactCompany

Aarti Pharmalabs Limited — Change in Management

NSE 2 hrs ago·31 Aug 2026, 2:16 pm

Aarti Pharmalabs

Aarti Pharmalabs Limited has announced a change in its management structure. The company has informed the stock exchanges about this development, which involves the appointment of a new Chief Executive Officer and other key leadership roles.

This news is significant for investors as leadership changes can impact a company's strategic direction, operational efficiency, and long-term growth prospects. Investors will closely monitor how the new management team plans to steer the company's business strategy and execution.

Moving forward, market participants should watch for official statements from the company regarding the new leadership's vision and any immediate changes in business operations. It is advisable to wait for more clarity before making any investment decisions.